Table 3.
Final mixed model including USTE TLs, length of treatment and age of the patient at the first USTE dose
| Estimate for: logF-CPT | 95% CI | P-value | No. of observations | No. of patients | |
|---|---|---|---|---|---|
| Ustekinumab level (μg/mL) | −0.0096 | −0.0263–0.0069 | 0.26 | 249 | 43 |
| Length of the treatment (days) | −0.0010 | −0.0015 to −0.0006 | < 0.0001 | 249 | 43 |
| Age at the first ustekinumab dose | −0.0066 | −0.1573–0.144 | 0.93 | 249 | 43 |
CI confidence interval; F-CPT faecal calprotectin; TLs trough levels; USTE ustekinumab